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Objective: To investigate the reproductive and pregnancy outcomes of women after previous Cesarean
Scar Pregnancy.
Materials and methods: From January 2009 to December 2013, a total of 214 patients with CSP received
surgical evacuation treatment by means of dilation and suction evacuation and local resection of the
ectopic gestational mass. A telephone follow-up was conducted every year after CSP treatment. The
follow-up was ended on December 2014.
Results: Twenty-ﬁve patients were lost to follow-up due to loss of contacts. The previous medical records
of the remaining 189 women were reviewed. Fifty-eight women wished to give birth again. However, 48
(82.8%, 48/58) of them stopped the attempts to get pregnant because they were afraid of recurrent CSP
and the high risk of uterine rupture during the subsequent pregnancy. The other 10 women spontane-
ously attempted to get pregnant again, among whom 6 (60%, 6/10) succeeded with the birth of 7 healthy
babies. A total of 32 women conceived again, either in plan or by chance. Five women (15.6%, 5/32)
experiencing recurrent CSP.
Conclusion: Even though our result did not necessarily represent the true recurrence rate, our study
provided some evidence about the likelihood of fertility and recurrence risk for future pregnancies after
previous CSP.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Cesarean scar pregnancy (CSP) is an uncommon type of
ectopic pregnancy in which the gestational sac is implanted in
the myometrium and ﬁbrous tissue of the cesarean scar [1]. The
main purpose of treatment for CSP is to preserve fertility and
prevent severe complications such as uterine rupture and
excessive bleeding. There is still no consensus on the optimal
treatment for CSP among obstetricians. The reason is probably
the lack of data on fertility or subsequent pregnancy after
treatment for CSP [2]. Therefore, we conducted follow up of 189
CSP patients to investigate their reproductive and pregnancy
outcomes.y & Obstetrics, West China
, Sichuan, China.
bstetrics & Gynecology. PublishedMaterials and methods
This observational study was approved by the Institutional Re-
view Board in West China Second Hospital of Sichuan University in
Chengdu, China. Signed informed consent forms were collected
from all participants whose clinical data were analyzed.
In our hospital, patients were diagnosed with CSP according to
cesarean delivery history, serum b-human chorionic gonadotro-
phin (b-hCG) level and ultrasonography. Ultrasound diagnosis was
made according to the following criteria [3]: (1) an empty uterine
cavity with a clearly demonstrated endometrium; (2) an empty
cervical canal; (3) the gestational sac was located in the anterior
part of the uterine isthmus, with decreased myometrial thickness
between the bladder and the sac; and (4) the gestational sac was
implanted in the myometrium and ﬁbrous tissue of the cesarean
delivery scar.
From January 2009 to December 2013, 214 patients with CSP
received surgical evacuation by means of dilation and suction
curettage (D&C) and local resection of the ectopic gestational massby Elsevier Taiwan LLC. All rights reserved.
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tion). All the above 214 patients were included in the observation.
Telephone follow up was conducted every year after CSP treatment
and ended on October 31, 2014. All the telephone calls were
completed by two of the authors (QW and HP). After the ques-
tionnaire had been drafted and approved by all the authors, QW
and HP invited ﬁve patients in our hospital to test whether the
questionnaire could be easily and correctly understood. The ques-
tionnaire consisted of three sections: basic information, review of
previous CSP medical data, and subsequent reproductive outcome
information.
Results
Twenty-ﬁve patients were lost to follow up due to loss of con-
tacts. The previous medical records of the remaining 189 women
were reviewed. One hundred and ﬁve were treated through uterine
artery embolization (UAE) combined with D&C within 72 hours of
diagnosis of CSP. Fifty-three women underwent D&C alone. The
other 31 received surgical resection.
According to the results of telephone follow up, 58 women
wished to give birth again. However, 48 (82.8%) of them stopped
attempting to become pregnant because they were afraid of
recurrent CSP and the high risk of uterine rupture during the
subsequent pregnancy. The other 10 women spontaneously
attempted to become pregnant again; six of whom succeeded with
the birth of seven healthy babies. All six of these women were
previously treated by UAE combined with D&C for CSP.
A total of 32 women conceived again, either planned or by
chance (Figure 1). The median time interval between previous CSP
treatment and subsequent conception was 32 months (range 4e62
months). No miscarriage was reported. The above-mentioned six
women had successful full-term cesarean deliveries. The median
blood loss during subsequent CS operation was 450 mL (rangeFigure 1. Distribution of pregnant women. CSP ¼ cesarean scar pregnancy; D300e1000 mL). No placenta previa or placenta accreta was found.
The remaining 26 women received induced abortion due to un-
wanted pregnancy. CSP was excluded via ultrasound before
termination. Five women (15.6%) who experienced recurrent CSP
were treated successfully with UAE combined with D&C without
any severe complications. For the other 21 with intrauterine
pregnancy, no excessive hemorrhage or other severe complication
in abortion operation was reported. The characteristics of women
with successful subsequent delivery and women with recurrent
CSP are shown in Table 1.
Discussion
According to the results of our follow up, the recurrence rate of
CSP was 15.6%. Moreover, this study showed that many women
decided not to carry again merely because of fear of the recurrence
of CSP. However, many women (60%) who wished and attempted
to have babies after previous CSP managed to have a term
pregnancy.
CSP is a rare iatrogenic complication with a rate of 0.15% in
women with previous cesarean delivery and has an estimated
incidence of 1/1800 to 1/2226 [1]. Over the past 10 years, the
incidence of CSP has increased due to the increase in CSs, especially
in China [4]. There are many CSP therapies that can preserve the
uterus and subsequent fertility. However, there is still no consensus
on the optimal management of CSP among obstetricians. This is
partly because of the limited information about the likelihood of
subsequent fertility and the risk of recurrent CSP after previous
treatment. Although preserving fertility is one of the most impor-
tant purposes of the treatment for CSP, there is still a chance of
recurrence. This was the main concern of the women who wished
to give birth again.
To date, few data on fertility or pregnancy after treatment for
CSP have been reported. Seow et al [5] noted seven pregnancies (8&C ¼ dilation and suction curettage; UAE ¼ uterine artery embolization.
Table 1
Characteristics of women with successful subsequent deliveries and women with recurrent CSP.
Case no. Year Previous CSP Subsequent pregnancy
GnPn CS (no.) Age (y) GA (wk) Treatment Interval (mo) Outcome Term (wk) Management
1 2011 G5P2þ3 1 31 11þ2 UAE þ D&C 26 Full-term delivery 38þ3 CS, birth weight: 3.75 kg
2 2011 G4P2þ2 1 30 8þ1 UAE þ D&C 32 Full-term delivery 37þ1 CS, birth weight: 2.86/2.60 kg
3 2012 G4P2þ2 1 29 8 UAE þ D&C 9 Full-term delivery 38þ6 CS, birth weight: 3.15 kg
4 2013 G4P2þ2 1 34 8þ4 UAE þ D&C 15 Full-term delivery 38þ2 CS, birth weight: 3.5 kg
5 2012 G6P2þ4 1 34 8þ4 UAE þ D&C 18 Full-term delivery 38þ1 CS, birth weight: 3.35 kg
6 2010 G6P2þ4 1 35 7þ1 UAE þ D&C 13 Full-term delivery 37 CS, birth weight: 2.95 kg
7 2009 G4P1þ3 1 30 7þ1 UAE þ laparotomy 62 Recurrent CSP 8þ6 UAE þ laparotomy
8 2009 G6P2þ4 2 30 6þ4 UAE þ D&C 64 Recurrent CSP 7þ1 UAE þ D&C
9 2009 G8P1þ7 1 35 7þ1 UAE þ D&C 20 Recurrent CSP 6þ1 UAE þ D&C
10 2013 G5P1þ4 1 37 6þ2 UAE þ D&C 9 Recurrent CSP 7 UAE þ D&C
11 2013 G7P2þ5 2 31 6þ1 UAE þ D&C 12 Recurrent CSP 6þ4 UAE þ D&C
CS ¼ cesarean section; CSP ¼ cesarean scar pregnancy; D&C ¼ dilation and suction curettage; GA ¼ gestational age; UAE ¼ uterine artery embolization; GnPn ¼ Gravida and
Para, which denote a state of pregnancy at the time of follow-up.
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nancies. Wang et al [6] reviewed 32 cases of CSP treated with
laparotomy/hysterotomy or medical treatment. Seven patients had
subsequent pregnancies following treatment of CSP. Daeun et al [2]
reported two successful live births following laparoscopic repair
and one of preterm birth after exploratory laparotomy for symp-
tomatic CSP. Qian et al [7] reported cesarean delivery history in
rural community hospitals, thinner lower uterine segment, gesta-
tional sac bulging into the uterovesical fold, and presentation of
positive symptoms as risk factors for recurrent CSP. Zhang et al [8]
suggested surgical resection of CSP with repair of CS scar as an
option that could reduce recurrence of CSP by removing the ce-
sarean scar together with the pregnancy tissue. Meanwhile, none of
the studies reported any information about the recurrence rate of
CSP in subsequent pregnancy.
In our present study, the rate of repeated CSP was ~15.6% in our
hospital, while the reported rate of primary CSP in women with
previous CS was only 0.15%. Even though our result did not
necessarily represent the true recurrence rate, these datamight still
provide some important information about recurrent CSP. A ma-
jority of patients diagnosed with CSP were referred to our hospital
since it is one of the largest Grade A tertiary gynecological centers
in Southwestern China. These patients comprised a large propor-
tion of the population included in our study.
In the follow up, six women previously treated by UAE com-
bined with D&C gave birth to seven healthy babies. The pregnancy
rate was 60% in the group of women who willingly attempted to
conceive again, with a live birth rate of 100%. All deliveries were
full-term and performed successfully through planned CS with no
postpartum complications. Of the ﬁve women with recurrent CSP,
one was previously treated by UAE followed by laparotomy resec-
tion of CSP and repair of uterine scar defect, while the other four
received combined therapy with UAE and D&C.
The combined therapy was considered to be effective in the
treatment of CSPwith a high success rate and reduced complication
risk [9]. According to our study, UAE combinedwith D&C seemed to
be safe in women who wanted to become pregnant again, since all
the successful subsequent deliveries happened in the women pre-
viously treated with combined therapy. However, most of the
repeated CSP also occurred in this group.
There were several limitations in our study. First, our study was
observational. This outcome might be inﬂuenced by the treatment
selection of the obstetricians in clinical work. Preventive UAE fol-
lowed by D&C is the most favorable therapy for stable CSP in our
hospital. After diagnosis was reached, the patient underwent
extensive riskebeneﬁt counseling, including a discussion ofalternative therapies and a review of the risks involved. Informed
consent was obtained from all patients before treatment. Individ-
ualized management strategies were adopted, depending on spe-
ciﬁc conditions of each patient. Factors, such as hemodynamic
status, gestational age, serum b-hCG level, ultrasonographic ﬁnd-
ings, and patients' request, were comprehensively considered. The
most common primary treatments were UAE combined with D&C,
followed by D&C alone. Second, since a large proportion of women
were using birth control after previous CSP, the number of subse-
quent pregnancies was small in our study. Thus, the potential as-
sociation between previous treatment, recurrent CSP, and
successful subsequent delivery could not be further evaluated
because of the study design and relatively small sample size. More
prospective studies with large population are still needed.
In conclusion, we reported the ﬁrst long-term follow up of
reproductive outcomes after previous CSP treatment, with a
recurrence rate of 15.6% and successful pregnancy rate of 60%. Our
study provided some evidence about the likelihood of fertility and
recurrence risk for future pregnancies after previous CSP.Conﬂicts of interest
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